KNG1 and acute graft versus host disease: Open-label, single-group assignment study to assess the safety and tolerability of the transfer of BK-specific T cells. Safety will be assessed by determining the incidence and severity of acute infusion-related toxicities and the rejection of allograft acute GVHD. Efficacy will be determined by a decrease in BK viral load, BK clearance, and the resolution of clinical BK organ disease by week 12